Once more confirmed: Adjuvant radiotherapy and improved local control provide a significant survival benefit for early breast cancer patients

Strahlentherapie und Onkologie

Volumn 182, Issue 4, 2006, Pages 199-201

  Sautter Bihl, Marie Luise ^a,c   Sauer, Rolf ^b  

^a Municipal Hospital Karlsruhe   (Germany)

^b UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^c STÄDTISCHES KLINIKUM KARLSRUHE   (Germany)

Author keywords

Accelerated partial breast irradiation; Adjuvant radiotherapy; Breast cancer

Indexed keywords

BREAST CANCER; CANCER CONTROL; CANCER MORTALITY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RISK; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; EARLY CANCER; EDITORIAL; HUMAN; MASTECTOMY; POSTOPERATIVE CARE; QUANTITATIVE ANALYSIS; RECURRENCE RISK; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME;

BREAST NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPHATIC METASTASIS; MASTECTOMY; MASTECTOMY, SEGMENTAL; META-ANALYSIS; NEOPLASM RECURRENCE, LOCAL; RADIOTHERAPY, ADJUVANT; RANDOMIZED CONTROLLED TRIALS; RISK FACTORS; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 33645841971     PISSN: 01797158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00066-006-6701-4     Document Type: Editorial

References (19)

1. Early Breast Cancer Trialists' Collaborative Group. Effects of radiotherapy and surgery in early breast cancer. An overview of the randomised trials. N Engl J Med 1995;30:1444-55.
2. Early Breast Cancer Trialists' Collaborative Group. Favourable and unfavourable effects on long term survival of radiotherapy for early breast cancer: an overview of the randomized trials. Lancet 2000;355:1757-70.
3. Early Breast Cancer Trialists' Collaborative Group. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrences and 15-year survival: an overview of the randomised trials. Lancet 2005;365:1687-717.
4. Early Breast Cancer Trialists' Collaborative Group. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005;366:2087-106.
5. Goldhirsch A, Coates AS, Colleoni M, et al. Radiotherapy and chemotherapy in high risk breast cancer [letter]. N Engl J Med 1998;338:330.
6. Hehr T, Classen J, Huth M, et al. Postmastectomy radiotherapy of the chest wall. Comparison of electron-rotation technique and common tangential photon fields. Strahlenther Onkol 2004;180:629-36.
7. Hellman S. Stopping metastases at their source. N Engl J Med 1997;337:996-7.
8. Overgaard M, Hansen PS, Overgaard J, et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. N Engl J Med 1997;337:949-55.
9. Overgaard M, Hansen PS, Overgaard J, et al. Postoperative radiotherapy in high-risk postmenopausal breast cancer patients given adjuvant tamoxifen. Danish Breast Cancer Cooperative Group DBCG 82 c randomized trial. Lancet 1999;353:1641-8.
10. Ragaz J, Jackson SM, Le N, et al. Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Engl J Med 1997;337:956-62.
11. Ragaz J, Olivotto JA, Spinelli JJ, et al. Locoregional radiation therapy in patients with high risk breast cancer receiving adjuvant chemotherapy: 20 year results of the British Columbia randomized trial. J Natl Cancer Inst 2005;97:116-26.
12. Reitsamer R, Peintinger F, Kopp M, et al. Local recurrence rates in breast cancer patients treated with intraoperative electron-boost radiotherapy versus postoperative external-beam electron-boost irradiation. A sequential intervention study. Strahlenther Onkol 2004;180:38-44.
13. Sauer R, Wenz F, Strnad V, et al. Teilbrustbestrahlung nach brusterhaltender Operation bei Brustkrebs. Strahlenther Onkol 2005;181:417-23.
14. Sauer R, für die Expertengruppe der DEGRO. Leitlinie: Radiotherapie des Mammakarzinoms. Strahlenther Onkol 2006;182:Suppl I.
15. Schäfer M, Munter M, Sterzing F, et al. Measurements of characteristics of time pattern in dose delivery in step-and-shoot IMRT. Strahlenther Onkol 2005;181:587-94.
16. Tai P, Yu E, Cserni G, et al. Minimum follow-up time required for the estimation of statistical cure of cancer patients: verification using data from 42 cancer sites in the SEER database. BMC Cancer 2005;5:48-57.
17. Van de Steene J, Soete G, Storme G. Adjuvant radiotherapy for breast cancer significantly improves overall survival: the missing link. Radiother Oncol 2000;55:263-72.
18. Vinh-Hung V, Verschraegen C. Breast-conserving surgery with or without radiotherapy: pooled analysis for risks of ipsilateral breast tumor recurrence and mortality. J Natl Cancer Inst 2004;96:115-21.
19. Wolberg WH, Robins HI. Radiotherapy and chemotherapy in high-risk breast cancer [letter]. N Engl J Med 1998;338:329-30.